Claudia Fernandes Lorea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claudia Fernandes Lorea has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Bibiana Mello de Oliveira
Federal University of Health Sciences of Porto Alegre (UFCSPA)
4 shared publications - Têmis Maria Félix
Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
4 shared publications - Domingos Alves
Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Brazil
3 shared publications - Hiram Larangeira de Almeida Jr
Universidade Católica de Pelotas, Pelotas, RS, Brazil
3 shared publications - Antônia Larangeira de Almeida
Dermatology League, Universidade Federal de Pelotas, Pelotas, RS, Brazil
2 shared publications - Filipe Andrade Bernardi
Ribeirão Preto Medical School, University of São Paulo
2 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Springer Nature in Journal of Community Genetics
- Vol. 17 (5) , 107
Rare diseases in Brazil: a nationwide analysis of the diagnostic odyssey
Background: The diagnostic odyssey of individuals with rare diseases is prolonged and associated with clinical, emotional, and financial burden. In Brazil, data on diagnostic delays and their determinants remain scarce. Objective: This study aims to characterize the diagnostic odyssey of individuals with rare diseases using data from the Brazilian Rare Diseases Network (RARAS). Methods: This descriptive cross-sectional study analyzed ambispective data collected from 2018-2025 across RARAS centers nationwide. Diagnostic odyssey was defined as the time between symptom onset and definitive diagnosis. Prenatal and newborn screening diagnoses were excluded. Sociodemographic, clinical and etiological data were collected through a standardized REDCap-based instrument. Results: Among 18,625 unique participants, 12,048 had confirmed diagnoses and 5,984 met criteria for diagnostic odyssey analysis. The mean diagnostic interval was 6.21 years (± 8.41; median 2.94, IQR 0.80–8.13), indicating substantial heterogeneity. Longer delays were observed in individuals with symptom onset during adolescence. Patients referred during hospital admission experienced shorter diagnostic intervals. Regional differences were significant ( p <0.001), with longer intervals in the Southeast region. Mean time to diagnosis ranged from 2.01 (± 2.89) years (achondroplasia) to 16.40 (± 12.59) years (hereditary angioedema). Patients consulted a mean of 5.32 (± 9.63) physicians and accessed 3.15 (± 4.96) healthcare services before diagnosis. Diagnostic intervals varied by race/ethnicity and etiological category, with longer delays among those with molecular diagnoses, while no association was observed with socioeconomic class. Conclusion: The diagnostic odyssey for rare diseases in Brazil remains prolonged and heterogeneous, reflecting structural disparities, healthcare fragmentation, and diagnostic complexity. These findings suggest that delays are not driven solely by limited access to advanced diagnostics, but also by barriers in early recognition, referral pathways, and care coordination, underscoring the need for integrated strategies across the health system.
- 15 September 2026
- Published by Springer Nature in Journal of Community Genetics
- Vol. 17 (5) , 107
Open AccessRare diseases in Brazil: a nationwide analysis of the diagnostic odyssey
Background: The diagnostic odyssey of individuals with rare diseases is prolonged and associated with clinical, emotional, and financial burden. In Brazil, data on diagnostic delays and their determinants remain scarce. Objective: This study aims to characterize the diagnostic odyssey of individuals with rare diseases using data from the Brazilian Rare Diseases Network (RARAS). Methods: This descriptive cross-sectional study analyzed ambispective data collected from 2018-2025 across RARAS centers nationwide. Diagnostic odyssey was defined as the time between symptom onset and definitive diagnosis. Prenatal and newborn screening diagnoses were excluded. Sociodemographic, clinical and etiological data were collected through a standardized REDCap-based instrument. Results: Among 18,625 unique participants, 12,048 had confirmed diagnoses and 5,984 met criteria for diagnostic odyssey analysis. The mean diagnostic interval was 6.21 years (± 8.41; median 2.94, IQR 0.80–8.13), indicating substantial heterogeneity. Longer delays were observed in individuals with symptom onset during adolescence. Patients referred during hospital admission experienced shorter diagnostic intervals. Regional differences were significant ( p <0.001), with longer intervals in the Southeast region. Mean time to diagnosis ranged from 2.01 (± 2.89) years (achondroplasia) to 16.40 (± 12.59) years (hereditary angioedema). Patients consulted a mean of 5.32 (± 9.63) physicians and accessed 3.15 (± 4.96) healthcare services before diagnosis. Diagnostic intervals varied by race/ethnicity and etiological category, with longer delays among those with molecular diagnoses, while no association was observed with socioeconomic class. Conclusion: The diagnostic odyssey for rare diseases in Brazil remains prolonged and heterogeneous, reflecting structural disparities, healthcare fragmentation, and diagnostic complexity. These findings suggest that delays are not driven solely by limited access to advanced diagnostics, but also by barriers in early recognition, referral pathways, and care coordination, underscoring the need for integrated strategies across the health system.
- Open Access
- 23 August 2026
- Published by Wiley in JIMD Reports
- Vol. 67 (5) , e70113
Glucose Transporter Deficiency Syndrome Type 1 (Glut1‐ DS ): New Insights From a Brazilian Cohort of Patients
Glucose transporter deficiency syndrome type 1 (Glut1‐DS) is a rare neurometabolic disorder caused by pathogenic variants in SLC2A1 , characterized by epilepsy, neurodevelopmental delay, movement disorders, dysarthria, intellectual disability, and postnatal microcephaly. We aimed to characterize the natural history of a Brazilian cohort of patients with Glut1‐DS. Brazilian patients of all ages were included if they presented with clinical features consistent with Glut1‐DS and carried a pathogenic or likely pathogenic SLC2A1 variant. Forty patients were included (21 males; median age 9.1 years [IQR: 6.0–12.9]; median age at diagnosis 5.0 years [IQR: 3.0–9.9]), of whom 32 had the classical phenotype. The most frequent manifestations at inclusion were seizures (37/40), speech delay (34/40), and movement disorders (29/35). Thirty‐four patients (85%) were receiving ketogenic dietary therapy (27 classical ketogenic diet and 7 modified Atkins diet). Cerebrospinal fluid analysis was performed in 10 patients (27.5%), all of whom had hypoglycorrhachia. Genetic testing identified 31 distinct SLC2A1 variants, including 15 novel variants. Intrafamilial phenotypic variability was observed in one of four families with recurrent disease, and reduced penetrance was identified in one affected parent. Missense variants were generally associated with milder phenotypes than truncating variants. These findings expand the phenotypic and genotypic spectrum of Glut1‐DS, highlight the high proportion of previously unreported SLC2A1 variants in the Brazilian population, and reinforce the importance of comprehensive genetic evaluation and counseling for affected families.
- 23 August 2026
- Published by Wiley in JIMD Reports
- Vol. 67 (5) , e70113
Open AccessGlucose Transporter Deficiency Syndrome Type 1 (Glut1‐ DS ): New Insights From a Brazilian Cohort of Patients
Glucose transporter deficiency syndrome type 1 (Glut1‐DS) is a rare neurometabolic disorder caused by pathogenic variants in SLC2A1 , characterized by epilepsy, neurodevelopmental delay, movement disorders, dysarthria, intellectual disability, and postnatal microcephaly. We aimed to characterize the natural history of a Brazilian cohort of patients with Glut1‐DS. Brazilian patients of all ages were included if they presented with clinical features consistent with Glut1‐DS and carried a pathogenic or likely pathogenic SLC2A1 variant. Forty patients were included (21 males; median age 9.1 years [IQR: 6.0–12.9]; median age at diagnosis 5.0 years [IQR: 3.0–9.9]), of whom 32 had the classical phenotype. The most frequent manifestations at inclusion were seizures (37/40), speech delay (34/40), and movement disorders (29/35). Thirty‐four patients (85%) were receiving ketogenic dietary therapy (27 classical ketogenic diet and 7 modified Atkins diet). Cerebrospinal fluid analysis was performed in 10 patients (27.5%), all of whom had hypoglycorrhachia. Genetic testing identified 31 distinct SLC2A1 variants, including 15 novel variants. Intrafamilial phenotypic variability was observed in one of four families with recurrent disease, and reduced penetrance was identified in one affected parent. Missense variants were generally associated with milder phenotypes than truncating variants. These findings expand the phenotypic and genotypic spectrum of Glut1‐DS, highlight the high proportion of previously unreported SLC2A1 variants in the Brazilian population, and reinforce the importance of comprehensive genetic evaluation and counseling for affected families.
- Open Access
- 1 October 2025
- Published by Springer Nature in BMC Digital Health
- Vol. 3 (1) , 61
Paving the way for Brazil’s first national rare diseases registry: the RARAS data governance model
- 1 October 2025
- Published by Springer Nature in BMC Digital Health
- Vol. 3 (1) , 61
Open AccessPaving the way for Brazil’s first national rare diseases registry: the RARAS data governance model
- 7 April 2025
- Published by Elsevier in Seminars in Perinatology
- Vol. 49 (4) , 152075
Infections during pregnancy: An ongoing threat
- 7 April 2025
- Published by Elsevier in Seminars in Perinatology
- Vol. 49 (4) , 152075
Infections during pregnancy: An ongoing threat
- Open Access
- 1 January 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (1) , 58-62
Síndrome de McCune‐Albright: relato de caso com exame de microscopia eletrônica de transmissão
- 1 January 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (1) , 58-62
Open AccessSíndrome de McCune‐Albright: relato de caso com exame de microscopia eletrônica de transmissão
- Open Access
- 25 November 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (1) , 58-62
McCune-Albright syndrome – A case report with transmission electron microscopy
- 25 November 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 97 (1) , 58-62
Open AccessMcCune-Albright syndrome – A case report with transmission electron microscopy
- Open Access
- 3 May 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (19)
Biallelic splicing variants in the nucleolar 60S assembly factor RBM28 cause the ribosomopathy ANE syndrome
Significance: RBM28 is a human protein essential for proper assembly of the large ribosomal subunit, crucially enabling synthesis of all cellular proteins. Defects in RBM28 cause rare ribosomopathies: alopecia, neurological defects, and endocrinopathy (ANE) syndrome. We investigated an ANE syndrome patient with a clinical presentation consistent with the definition of ANE syndrome but possessing differing genetic variants and molecular pathology. We find one inherited allele is null, clarifying that ANE syndrome is not caused by RBM28 haploinsufficiency, while the other inherited allele retains enough function to enable survival but preclude proper development. Our results define an underlying pathology of ANE syndrome, further delineating an emerging class of assembly factor ribosomopathies and underscoring the importance of nucleolar processes in human health.
- 3 May 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (19)
Open AccessBiallelic splicing variants in the nucleolar 60S assembly factor RBM28 cause the ribosomopathy ANE syndrome
Significance: RBM28 is a human protein essential for proper assembly of the large ribosomal subunit, crucially enabling synthesis of all cellular proteins. Defects in RBM28 cause rare ribosomopathies: alopecia, neurological defects, and endocrinopathy (ANE) syndrome. We investigated an ANE syndrome patient with a clinical presentation consistent with the definition of ANE syndrome but possessing differing genetic variants and molecular pathology. We find one inherited allele is null, clarifying that ANE syndrome is not caused by RBM28 haploinsufficiency, while the other inherited allele retains enough function to enable survival but preclude proper development. Our results define an underlying pathology of ANE syndrome, further delineating an emerging class of assembly factor ribosomopathies and underscoring the importance of nucleolar processes in human health.
- 17 June 2020
- Published by Georg Thieme Verlag KG in Journal of Pediatric Genetics
- Vol. 09 (04) , 227-234
Congenital Heart Defects and Dysmorphic Facial Features in Patients Suspicious of 22q11.2 Deletion Syndrome in Southern Brazil
22q11.2 deletion syndrome (22q11.2DS) is considered one of the most frequently observed chromosomal abnormalities in association with congenital heart disease (CHD), which can also include some combination of other features. Thus, the aim of this work was to verify the profile of dysmorphic features and heart defects found in patients referred to a reference center in Southern Brazil with clinical findings suggestive of 22q11.2DS. In the overall sample group, only patients with dysmorphic facial features (skull, eyes, ear, and nose) associated with CHD (obstructive pulmonary valve ring, truncus arteriosus, and bicuspid aortic valve associated with atrial septal defect and/or right aortic arch) had a 22q11.2 deletion. These findings proved to be reliable clinical criteria for referral to perform fluorescent in situ hybridization investigation for 22q11.2 deletion.
- 17 June 2020
- Published by Georg Thieme Verlag KG in Journal of Pediatric Genetics
- Vol. 09 (04) , 227-234
Congenital Heart Defects and Dysmorphic Facial Features in Patients Suspicious of 22q11.2 Deletion Syndrome in Southern Brazil
22q11.2 deletion syndrome (22q11.2DS) is considered one of the most frequently observed chromosomal abnormalities in association with congenital heart disease (CHD), which can also include some combination of other features. Thus, the aim of this work was to verify the profile of dysmorphic features and heart defects found in patients referred to a reference center in Southern Brazil with clinical findings suggestive of 22q11.2DS. In the overall sample group, only patients with dysmorphic facial features (skull, eyes, ear, and nose) associated with CHD (obstructive pulmonary valve ring, truncus arteriosus, and bicuspid aortic valve associated with atrial septal defect and/or right aortic arch) had a 22q11.2 deletion. These findings proved to be reliable clinical criteria for referral to perform fluorescent in situ hybridization investigation for 22q11.2 deletion.